
Bio-Rad Laboratories, Inc.
BIONYSECIK 12208TechnologyFiscal year ends Dec 31
Reports and events: 266 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-10-1717:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-257773 |
| 2023-08-2516:52 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000012208-23-000065 |
| 2023-08-0416:31 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000012208-23-000063 |
| 2023-08-0316:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000012208-23-000062 |
| 2023-07-2016:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000012208-23-000058 |
| 2023-06-0508:45 ET | 8-K | 7.01 Regulation FD disclosure | 0000012208-23-000054 |
| 2023-05-0516:31 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000012208-23-000047 |
| 2023-05-0416:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000012208-23-000045 |
| 2023-05-0116:30 ET | 8-K | 5.07 Shareholder vote results | 0000012208-23-000041 |
| 2023-03-2916:31 ET | DEF 14A | Proxy statement | 0001308179-23-000427 |
| 2023-02-2316:06 ET | 8-K | 7.01 Regulation FD disclosure | 0000012208-23-000035 |
| 2023-02-1717:07 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000012208-23-000031 |
| 2023-02-1616:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000012208-23-000025 |
| 2023-01-1016:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000012208-23-000009 |
| 2022-11-0808:30 ET | 8-K | 7.01 Regulation FD disclosure | 0000012208-22-000080 |
| 2022-10-2817:13 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000012208-22-000071 |
| 2022-10-2716:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000012208-22-000065 |
| 2022-07-2916:07 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000012208-22-000046 |
| 2022-07-2816:57 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000012208-22-000040 |
| 2022-05-1816:45 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-22-154095 |
| 2022-04-2916:12 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000012208-22-000026 |
| 2022-04-2816:25 ET | 8-K | 2.02 Results of operations | 0000012208-22-000021 |
| 2022-04-2016:46 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-22-111203 |
| 2022-04-1116:46 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-22-101752 |
| 2022-03-3016:45 ET | DEF 14A | Proxy statementPeriod 2022-04-26 | 0001308179-22-000148 |
| 2022-03-2816:47 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-086770 |
| 2022-03-0217:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-063143 |
| 2022-02-2509:19 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-053527 |
| 2022-02-1116:35 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000012208-22-000011 |
| 2022-02-1016:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000012208-22-000005 |
| 2021-11-2917:20 ET | 8-K | 8.01 Other events | 0001193125-21-342427 |
| 2021-11-1816:46 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-21-333913 |
| 2021-10-2916:06 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000012208-21-000050 |
| 2021-10-2816:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000012208-21-000045 |
| 2021-10-0416:46 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-291024 |
| 2021-07-3016:33 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0000012208-21-000039 |
| 2021-07-2916:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000012208-21-000034 |
| 2021-04-3016:56 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0000012208-21-000024 |
| 2021-04-2916:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000012208-21-000019 |
| 2021-03-3116:47 ET | DEF 14A | Proxy statementPeriod 2021-04-27 | 0001308179-21-000130 |
| 2021-02-1621:00 ET | 10-K | Annual reportPeriod 2020-12-31 | 0000012208-21-000012 |
| 2021-02-1117:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000012208-21-000008 |
| 2021-02-0406:11 ET | 8-K | 2.05 Exit or disposal costs | 0001193125-21-027959 |
| 2020-12-1017:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-315015 |
| 2020-10-3016:34 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0000012208-20-000055 |
| 2020-10-2916:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000012208-20-000049 |
| 2020-07-3116:01 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0000012208-20-000039 |
| 2020-07-3018:59 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000012208-20-000034 |
| 2020-05-2116:54 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-20-148781 |
| 2020-05-0821:55 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0000012208-20-000022 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 22:50 ET. Listed shows no prices and gives no investment advice.